To date, the lack of chemo-naive cell models limited exploratory studies to define novel therapies for Burkitt lymphoma (BL). To obtain a useful tool for biological and translational studies for this tumor, we established the RALE051 cell line from the malignant ascitic fluid cells of a patient at initial diagnosis, not previously exposed to any treatment. The cell line was characterized by karyotyping, fluorescence in situ hybridization (FISH), single nucleotide polymorphism (SNP) array, immunohistochemistry, and RNA-Seq, revealing the persistence of biological and molecular features observed in the primary ascitic fluid, such as the cell morphology and immunophenotype, the occurrence of a t(8;22) translocation deregulating MYC, knock-out ID3 mutations in a compound homozygous state, and a mutated TP53. Moreover, additional alterations characterizing the ex vivo transformation included the emergence of three novel fusion transcripts and a nonsense mutation affecting TP53. The establishment of this cell line would be beneficial for future biological and therapeutic studies of BL.
RALE051: a novel established cell line of sporadic Burkitt lymphoma / L'Abbate, Alberto; Iacobucci, Ilaria; Lonoce, Angelo; Turchiano, Antonella; Ficarra, Elisa; Paciello, Giulia; Cattina, Federica; Ferrari, Anna; Imbrogno, Enrica; Agostinelli, Claudio; Zinzani, Pier Luigi; Martinelli, Giovanni; Derenzini, Enrico; Storlazzi, Clelia Tiziana. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - ELETTRONICO. - 59:5(2018), pp. 1252-1255. [10.1080/10428194.2017.1372580]
RALE051: a novel established cell line of sporadic Burkitt lymphoma
Iacobucci, Ilaria;Ficarra, Elisa;Cattina, Federica;Ferrari, Anna;Imbrogno, Enrica;Agostinelli, Claudio;Zinzani, Pier Luigi;Martinelli, Giovanni;Derenzini, Enrico;Storlazzi, Clelia Tiziana
2018
Abstract
To date, the lack of chemo-naive cell models limited exploratory studies to define novel therapies for Burkitt lymphoma (BL). To obtain a useful tool for biological and translational studies for this tumor, we established the RALE051 cell line from the malignant ascitic fluid cells of a patient at initial diagnosis, not previously exposed to any treatment. The cell line was characterized by karyotyping, fluorescence in situ hybridization (FISH), single nucleotide polymorphism (SNP) array, immunohistochemistry, and RNA-Seq, revealing the persistence of biological and molecular features observed in the primary ascitic fluid, such as the cell morphology and immunophenotype, the occurrence of a t(8;22) translocation deregulating MYC, knock-out ID3 mutations in a compound homozygous state, and a mutated TP53. Moreover, additional alterations characterizing the ex vivo transformation included the emergence of three novel fusion transcripts and a nonsense mutation affecting TP53. The establishment of this cell line would be beneficial for future biological and therapeutic studies of BL.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.